Status:
ACTIVE_NOT_RECRUITING
Mixed-Methods Evaluation of Short-, Medium-, and Long-Term Outcomes Following Hip Treatment
Lead Sponsor:
Mayo Clinic
Conditions:
Hip Dysplasia
Legg-Calvâe-Perthes Disease
Eligibility:
All Genders
18+ years
Brief Summary
This study, titled "Mixed-Methods Evaluation of Short-, Medium-, and Long-Term Outcomes Following Hip Treatment," aims to assess the long-term effectiveness of treatments for pediatric hip conditions,...
Detailed Description
Conducted at Mayo Clinic, the study combines retrospective chart reviews and prospective follow-up to gather data on clinical outcomes, radiographic measures, and patient-reported outcomes (PROs) like...
Eligibility Criteria
Inclusion
- Patients over the age of 18 seen for a concern of hip pathology at Mayo between 1975 and 2024
- Patients over 18 who can be contacted for follow-up and are willing to participate.
Exclusion
- Patients presenting over age 18 for hip dysplasia
- Patients who are unwilling to complete follow up surveys.
Key Trial Info
Start Date :
January 15 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 15 2026
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06891196
Start Date
January 15 2025
End Date
January 15 2026
Last Update
March 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905